Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

DNA Polymerases as Therapeutic Targets

Identifieur interne : 003224 ( Main/Exploration ); précédent : 003223; suivant : 003225

DNA Polymerases as Therapeutic Targets

Auteurs : Anthony J. Berdis [États-Unis]

Source :

RBID : ISTEX:B188230197D738AA3642902121008BEB3A6F9431

Abstract

Numerous pathological states, including cancer, autoimmune diseases, and viral/bacterial infections, are often attributed to uncontrollable DNA replication. Inhibiting this essential biological process provides an obvious therapeutic target against these diseases. A logical target is the DNA polymerase, the enzyme responsible for catalyzing the addition of mononucleotides to a growing polymer using a DNA or RNA template as a guide for directing each incorporation event. This review provides a summary of therapeutic agents that target polymerase activity. A discussion of the biological function and mechanism of polymerases is first provided to illustrate the strategy for therapeutic intervention as well as the rational design of various nucleoside analogues that inhibit various polymerases associated with viral infections and cancer. The development of nucleoside and non-nucleoside inhibitors as antiviral agents is discussed with particular emphasis on their mechanism of action, structure−activity relationships, toxicity, and mechanism of resistance. In addition, commonly used anticancer agents are described to illustrate the similarities and differences associated with various nucleoside analogues as therapeutic agents. Finally, new therapeutic approaches that include the inhibition of selective polymerases involved in DNA repair and/or translesion DNA synthesis as anticancer agents are discussed.

Url:
DOI: 10.1021/bi801179f


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>DNA Polymerases as Therapeutic Targets</title>
<author>
<name sortKey="Berdis, Anthony J" sort="Berdis, Anthony J" uniqKey="Berdis A" first="Anthony J." last="Berdis">Anthony J. Berdis</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:B188230197D738AA3642902121008BEB3A6F9431</idno>
<date when="2008" year="2008">2008</date>
<idno type="doi">10.1021/bi801179f</idno>
<idno type="url">https://api.istex.fr/ark:/67375/TPS-TKGPZQG7-9/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000D69</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000D69</idno>
<idno type="wicri:Area/Istex/Curation">000D69</idno>
<idno type="wicri:Area/Istex/Checkpoint">000E98</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000E98</idno>
<idno type="wicri:doubleKey">0006-2960:2008:Berdis A:dna:polymerases:as</idno>
<idno type="wicri:Area/Main/Merge">003326</idno>
<idno type="wicri:Area/Main/Curation">003224</idno>
<idno type="wicri:Area/Main/Exploration">003224</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main">DNA Polymerases as Therapeutic Targets
<ref type="bib" target="#caf1"></ref>
</title>
<author>
<name sortKey="Berdis, Anthony J" sort="Berdis, Anthony J" uniqKey="Berdis A" first="Anthony J." last="Berdis">Anthony J. Berdis</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Ohio</region>
</placeName>
<wicri:cityArea>Department of Pharmacology, Case Western Reserve University, 10900 Euclid Avenue, Cleveland</wicri:cityArea>
</affiliation>
<affiliation wicri:level="1">
<country wicri:rule="url">États-Unis</country>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">Biochemistry</title>
<title level="j" type="abbrev">Biochemistry</title>
<idno type="ISSN">0006-2960</idno>
<idno type="eISSN">1520-4995</idno>
<imprint>
<publisher>American Chemical Society</publisher>
<date type="e-published">2008</date>
<date type="published">2008</date>
<biblScope unit="vol">47</biblScope>
<biblScope unit="issue">32</biblScope>
<biblScope unit="page" from="8253">8253</biblScope>
<biblScope unit="page" to="8260">8260</biblScope>
</imprint>
<idno type="ISSN">0006-2960</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0006-2960</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract">Numerous pathological states, including cancer, autoimmune diseases, and viral/bacterial infections, are often attributed to uncontrollable DNA replication. Inhibiting this essential biological process provides an obvious therapeutic target against these diseases. A logical target is the DNA polymerase, the enzyme responsible for catalyzing the addition of mononucleotides to a growing polymer using a DNA or RNA template as a guide for directing each incorporation event. This review provides a summary of therapeutic agents that target polymerase activity. A discussion of the biological function and mechanism of polymerases is first provided to illustrate the strategy for therapeutic intervention as well as the rational design of various nucleoside analogues that inhibit various polymerases associated with viral infections and cancer. The development of nucleoside and non-nucleoside inhibitors as antiviral agents is discussed with particular emphasis on their mechanism of action, structure−activity relationships, toxicity, and mechanism of resistance. In addition, commonly used anticancer agents are described to illustrate the similarities and differences associated with various nucleoside analogues as therapeutic agents. Finally, new therapeutic approaches that include the inhibition of selective polymerases involved in DNA repair and/or translesion DNA synthesis as anticancer agents are discussed.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Ohio</li>
</region>
</list>
<tree>
<country name="États-Unis">
<region name="Ohio">
<name sortKey="Berdis, Anthony J" sort="Berdis, Anthony J" uniqKey="Berdis A" first="Anthony J." last="Berdis">Anthony J. Berdis</name>
</region>
<name sortKey="Berdis, Anthony J" sort="Berdis, Anthony J" uniqKey="Berdis A" first="Anthony J." last="Berdis">Anthony J. Berdis</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003224 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003224 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:B188230197D738AA3642902121008BEB3A6F9431
   |texte=   DNA Polymerases as Therapeutic Targets
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021